Heart Failure in Women: A Personalized Medicine Approach
Author Information
Author(s): Carmen Ginghin̆, C Botezatu, CD Serban, M Jurcuţ
Primary Institution: Cardiology Clinic of ‘Prof. Dr. C. C. Iliescu’ Institute of Cardiovascular Diseases
Hypothesis
Are there significant gender differences in heart failure presentation and management that warrant a personalized medicine approach?
Conclusion
Heart failure in women presents unique challenges and characteristics that require tailored management strategies.
Supporting Evidence
- Women are generally older at heart failure onset and often do not have left ventricular systolic dysfunction.
- Gender-specific differences in gene expression may explain the clinical differences in heart failure between men and women.
- Women are underrepresented in clinical trials, with only 20% of heart failure patients being women.
Takeaway
Women experience heart failure differently than men, and understanding these differences can help doctors treat them better.
Methodology
This is a review of existing data regarding heart failure in women, focusing on gender differences in presentation, risk factors, and treatment.
Potential Biases
There is a risk of bias due to the historical exclusion of women from clinical studies, leading to a lack of understanding of their specific needs.
Limitations
The review highlights the underrepresentation of women in clinical trials and the need for more gender-specific research.
Participant Demographics
The review discusses heart failure in women, particularly focusing on older women and those with specific risk factors like hypertension and diabetes.
Want to read the original?
Access the complete publication on the publisher's website